Potentiation of Anti-Glioma Immunity Induced by Oncolytic Adenovirus Delta-24-RGD Through Viral Expression of Immune Co-Stimulator OX40 Ligand

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Anti-Tumor Immunity Induced by Ectopic Expression of Viral Antigens Is Transient and Limited by Immune Escape

OncoImmunology
OncologyAllergyImmunology
2019English

Enhancing Anti-Prostate Cancer Immunity Through OX40 Engagement

2006English

Oncolytic Viral Therapy of Malignant Glioma

Neurotherapeutics
NeurologyPharmacology
2009English

842. Increased Oncolytic Ability of a Double RGD-Modified Adenovirus in Ovarian Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Small-Molecule Modulators of the OX40-OX40 Ligand Co-Stimulatory Protein-Protein Interaction

British Journal of Pharmacology
Pharmacology
2014English

Delta-24-RGD Combined With Radiotherapy Exerts a Potent Antitumor Effect in Diffuse Intrinsic Pontine Glioma and Pediatric High Grade Glioma Models

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

A Novel Ad5/11 Chimeric Oncolytic Adenovirus for Improved Glioma Therapy

International Journal of Oncology
Cancer ResearchOncology
2012English

Editorial: Porcine Anti-Viral Immunity

Frontiers in Immunology
AllergyImmunology
2020English

Radiosensitization by Telomerase-Dependent Oncolytic Adenovirus

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy